Compare Aurobindo Pharma with J.B.Chemicals - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

AUROBINDO PHARMA vs J.B.CHEMICALS - Comparison Results

AUROBINDO PHARMA     Change

Aurobindo Pharma is one of India's top 5 pharma companies in terms of turnover, and has presence in the generic and Active Pharmaceutical Ingredients (API) segments. The company's robust product portfolio is spread across 6 product areas, including a... More

J.B.CHEMICALS 
   Change

JB Chemicals and Pharmaceuticals Limited (JBCPL), the flagship of the Unique Group, is one of the India's leading transnational pharmaceutical company. The company has 11 manufacturing facilities at four locations in India (Belapur, Ankleshwar, Panol... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    AUROBINDO PHARMA J.B.CHEMICALS AUROBINDO PHARMA/
J.B.CHEMICALS
 
P/E (TTM) x 16.8 37.7 44.5% View Chart
P/BV x 3.6 7.0 51.8% View Chart
Dividend Yield % 0.3 0.2 172.7%  

Financials

 AUROBINDO PHARMA   J.B.CHEMICALS
EQUITY SHARE DATA
    AUROBINDO PHARMA
Mar-19
J.B.CHEMICALS
Mar-18
AUROBINDO PHARMA/
J.B.CHEMICALS
5-Yr Chart
Click to enlarge
High Rs830363 228.6%   
Low Rs527255 206.7%   
Sales per share (Unadj.) Rs333.9169.1 197.4%  
Earnings per share (Unadj.) Rs40.416.6 243.1%  
Cash flow per share (Unadj.) Rs51.823.4 221.0%  
Dividends per share (Unadj.) Rs2.502.00 125.0%  
Dividend yield (eoy) %0.40.6 56.9%  
Book value per share (Unadj.) Rs237.1172.5 137.4%  
Shares outstanding (eoy) m585.9183.57 701.1%   
Bonus/Rights/Conversions ESOPBB-  
Price / Sales ratio x2.01.8 111.2%   
Avg P/E ratio x16.818.6 90.3%  
P/CF ratio (eoy) x13.113.2 99.3%  
Price / Book Value ratio x2.91.8 159.7%  
Dividend payout %6.212.0 51.4%   
Avg Mkt Cap Rs m397,56925,827 1,539.3%   
No. of employees `00017.93.8 473.4%   
Total wages/salary Rs m25,8492,511 1,029.4%   
Avg. sales/employee Rs Th10,956.93,747.4 292.4%   
Avg. wages/employee Rs Th1,447.7665.7 217.5%   
Avg. net profit/employee Rs Th1,324.3367.8 360.1%   
INCOME DATA
Net Sales Rs m195,63614,135 1,384.0%  
Other income Rs m1,553366 424.6%   
Total revenues Rs m197,18914,501 1,359.8%   
Gross profit Rs m39,5192,178 1,814.2%  
Depreciation Rs m6,680570 1,172.5%   
Interest Rs m2,62635 7,524.4%   
Profit before tax Rs m31,7671,940 1,637.9%   
Minority Interest Rs m270-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m-8810-   
Tax Rs m7,269552 1,316.0%   
Profit after tax Rs m23,6451,387 1,704.5%  
Gross profit margin %20.215.4 131.1%  
Effective tax rate %22.928.5 80.3%   
Net profit margin %12.19.8 123.2%  
BALANCE SHEET DATA
Current assets Rs m153,64510,470 1,467.5%   
Current liabilities Rs m120,4292,749 4,380.8%   
Net working cap to sales %17.054.6 31.1%  
Current ratio x1.33.8 33.5%  
Inventory Days Days13555 244.9%  
Debtors Days Days6478 82.0%  
Net fixed assets Rs m103,9095,811 1,788.1%   
Share capital Rs m586167 350.6%   
"Free" reserves Rs m138,32214,248 970.8%   
Net worth Rs m138,90814,416 963.6%   
Long term debt Rs m1,8000-   
Total assets Rs m264,54417,649 1,498.9%  
Interest coverage x13.156.6 23.2%   
Debt to equity ratio x00-  
Sales to assets ratio x0.70.8 92.3%   
Return on assets %9.98.1 123.2%  
Return on equity %17.09.6 176.9%  
Return on capital %23.813.7 174.0%  
Exports to sales %49.60-   
Imports to sales %18.80-   
Exports (fob) Rs m97,091NA-   
Imports (cif) Rs m36,741NA-   
Fx inflow Rs m97,3166,164 1,578.8%   
Fx outflow Rs m40,5891,334 3,041.7%   
Net fx Rs m56,7274,829 1,174.6%   
CASH FLOW
From Operations Rs m16,2201,231 1,318.2%  
From Investments Rs m-28,768-208 13,824.3%  
From Financial Activity Rs m19,191-595 -3,224.2%  
Net Cashflow Rs m6,656427 1,558.5%  

Share Holding

Indian Promoters % 54.1 55.4 97.7%  
Foreign collaborators % 0.0 0.3 -  
Indian inst/Mut Fund % 8.0 3.4 234.5%  
FIIs % 27.7 3.9 710.3%  
ADR/GDR % 0.0 0.0 -  
Free float % 10.2 37.0 27.6%  
Shareholders   69,601 30,437 228.7%  
Pledged promoter(s) holding % 8.6 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare AUROBINDO PHARMA With:   PIRAMAL ENTERPRISES  NOVARTIS  DR. DATSONS LABS  DR. REDDYS LAB  GSK PHARMA  

Compare AUROBINDO PHARMA With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Indian Indices End Flat, GAIL and UPL Among Top Nifty Gainers(Closing)

Indian share markets continued their volatile trend during closing hours today and ended their day on a flat note.

Related Views on News

AUROBINDO PHARMA Announces Quarterly Results (1QFY21); Net Profit Up 25.6% (Quarterly Result Update)

Sep 15, 2020 | Updated on Sep 15, 2020

For the quarter ended June 2020, AUROBINDO PHARMA has posted a net profit of Rs 8 bn (up 25.6% YoY). Sales on the other hand came in at Rs 59 bn (up 8.8% YoY). Read on for a complete analysis of AUROBINDO PHARMA's quarterly results.

AUROBINDO PHARMA Announces Quarterly Results (4QFY20); Net Profit Up 48.2% (Quarterly Result Update)

Jun 5, 2020 | Updated on Jun 5, 2020

For the quarter ended March 2020, AUROBINDO PHARMA has posted a net profit of Rs 9 bn (up 48.2% YoY). Sales on the other hand came in at Rs 62 bn (up 16.4% YoY). Read on for a complete analysis of AUROBINDO PHARMA's quarterly results.

AUROBINDO PHARMA Announces Quarterly Results (3QFY20); Net Profit Down 0.5% (Quarterly Result Update)

Feb 7, 2020 | Updated on Feb 7, 2020

For the quarter ended December 2019, AUROBINDO PHARMA has posted a net profit of Rs 7 bn (down 0.5% YoY). Sales on the other hand came in at Rs 58 bn (up 10.1% YoY). Read on for a complete analysis of AUROBINDO PHARMA's quarterly results.

J.B.CHEMICALS Announces Quarterly Results (3QFY20); Net Profit Up 34.1% (Quarterly Result Update)

Feb 6, 2020 | Updated on Feb 6, 2020

For the quarter ended December 2019, J.B.CHEMICALS has posted a net profit of Rs 622 m (up 34.1% YoY). Sales on the other hand came in at Rs 4 bn (up 9.3% YoY). Read on for a complete analysis of J.B.CHEMICALS's quarterly results.

AUROBINDO PHARMA Announces Quarterly Results (2QFY20); Net Profit Up 4.6% (Quarterly Result Update)

Nov 15, 2019 | Updated on Nov 15, 2019

For the quarter ended September 2019, AUROBINDO PHARMA has posted a net profit of Rs 6 bn (up 4.6% YoY). Sales on the other hand came in at Rs 56 bn (up 17.9% YoY). Read on for a complete analysis of AUROBINDO PHARMA's quarterly results.

More Views on News

Most Popular

It's the Beginning of a New Bull Phase in Smallcaps(Profit Hunter)

Feb 24, 2021

Last time the smallcap index crossed 19k a big correction followed. Here's what makes it different this time.

Make Rs 5,000 Per Day Trading the Market(Fast Profits Daily)

Feb 25, 2021

In this video, I'll show you how to get started on the path to daily trading profits.

The Hidden Tesla in My Great Indian Wealth Project(Profit Hunter)

Feb 23, 2021

An Indian company founded three decades ago in a garage caught my attention...

Gold 65,000 and Silver 84,000 in 2022

Feb 26, 2021

In this episode of the Investor Hour, India's #1 trader, Vijay Bhambwani, talks to us about the stock market, his new targets for gold and silver, the best long-term investment opportunity, and a lot more.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

AUROBINDO PHARMA SHARE PRICE


Mar 8, 2021 (Close)

TRACK AUROBINDO PHARMA

  • Track your investment in AUROBINDO PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON AUROBINDO PHARMA

AUROBINDO PHARMA 5-YR ANALYSIS

COMPARE AUROBINDO PHARMA WITH

MARKET STATS